238 related articles for article (PubMed ID: 32344603)
1. Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis.
Fauchier L; Bodin A; Bisson A; Herbert J; Spiesser P; Clementy N; Babuty D; Chao TF; Lip GYH
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32344603
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
4. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
6. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
7. Changes in CHA
Tsiartas E; Samaras A; Papazoglou AS; Kartas A; Moysidis DV; Gemousakakis E; Kamzolas O; Bekiaridou A; Doundoulakis I; Tzikas A; Giannakoulas G
Heart Vessels; 2023 Oct; 38(10):1267-1276. PubMed ID: 37311823
[TBL] [Abstract][Full Text] [Related]
8. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
[TBL] [Abstract][Full Text] [Related]
9. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
10. Mortality Prediction of the CHA
Morrone D; Kroep S; Ricci F; Renda G; Patti G; Kirchhof P; Chuang LH; van Hout B; De Caterina R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317069
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
[TBL] [Abstract][Full Text] [Related]
12. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
13. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
14. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2014 Oct; 64(16):1658-65. PubMed ID: 25323252
[TBL] [Abstract][Full Text] [Related]
15. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
16. Performance of CHA
Kiviniemi T; Lehto J; Nissinen M; Nieminen T; Hartikainen J; Malmberg M; Yannopoulos F; Savolainen J; Karjalainen P; Airaksinen KEJ; Rosato S; Biancari F
J Thorac Cardiovasc Surg; 2019 Mar; 157(3):896-904. PubMed ID: 30174132
[TBL] [Abstract][Full Text] [Related]
17. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
[TBL] [Abstract][Full Text] [Related]
18. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
19. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
Akboğa MK; Yılmaz S; Yalçın R
Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]